Evidence map›Paper›PMID 37027379›Full record

ArticlePloS one2023

Enhancement of neutrophil chemotaxis by trans-anethole-treated Staphylococcus aureus strains.

Paweł Kwiatkowski, Aleksandra Tabiś, Peter Sobolewski, Wojciech Płaziński, Agata Pruss, Monika Sienkiewicz, Barbara Dołęgowska, Iwona Wojciechowska-Koszko

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Paweł KwiatkowskiDepartment of Diagnostic Immunology, Pomeranian Medical University in Szczecin, Szczecin, Poland.ORCID 0000-0003-0016-0541
Aleksandra TabiśDepartment of Food Hygiene and Consumer Health Protection, Wroclaw University of Environmental and Life Sciences, Wroclaw, Poland.
Peter SobolewskiDepartment of Polymer and Biomaterials Science, Faculty of Chemical Technology and Engineering, West Pomeranian University of Technology, Szczecin, Poland.
Wojciech PłazińskiJerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, Krakow, Poland.
Agata PrussDepartment of Laboratory Medicine, Pomeranian Medical University in Szczecin, Szczecin, Poland.
Monika SienkiewiczDepartment of Pharmaceutical Microbiology and Microbiological Diagnostic, Medical University of Lodz, Łódź, Poland.
Barbara DołęgowskaDepartment of Laboratory Medicine, Pomeranian Medical University in Szczecin, Szczecin, Poland.
Iwona Wojciechowska-KoszkoDepartment of Diagnostic Immunology, Pomeranian Medical University in Szczecin, Szczecin, Poland.
Pomeranian Medical University · PLMedical University of Lodz · PLMedical University of Lublin · PLWest Pomeranian University of Technology in Szczecin · PLWrocław University of Environmental and Life Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to analyze the chemotactic response of differentiated HL-60 neutrophil-like (dHL-60) cells to trans-anethole (TA)-treated Staphylococcus aureus strains. Special attention was paid to evaluate the influence of TA on the chp gene expression level, as well as molecular docking and molecular dynamics (MD) simulation studies on interactions of TA with chemotaxis inhibitory protein of S. aureus (CHIPS). The following parameters were studied: susceptibility to TA using the agar diffusion method, the chp gene detection and its expression under TA influence, and clonal diversity of S. aureus strains using molecular techniques. Furthermore, a chemotactic response of dHL-60 cells to TA-treated S. aureus using Boyden chamber assay was detected and molecular modeling using both the docking methodology and unbiased MD simulations was conducted. It was found that TA showed antibacterial activity against all strains. Three genotypes and one unique pattern were distinguished among the strains. 50% of the isolates were chp-positive. It was observed that TA reduced/inhibited chp gene expression in most S. aureus strains. Enhanced chemotactic response of dHL-60 cells to TA-treated S. aureus strains was also noted. This correlation was similar for both chp-positive and chp-negative strains. Both molecular docking and MD simulations studies confirmed that TA is preferentially bound in the complement component 5a/CHIPS interface interaction region and can interfere with any processes exploiting this binding cavity. It has been proven that dHL-60 cells exhibited a higher chemotactic response to TA-treated S. aureus strains in comparison to non-treated bacteria, regardless of the achieved expression of the chp gene or its lack. Nevertheless, further analyses are required to understand this mechanism better.

Indexed as

Staphylococcal InfectionsStaphylococcus aureusAllylbenzene DerivativesAnisolesAnti-Bacterial AgentsChemotaxisHumansMolecular Docking SimulationMolecular Dynamics SimulationNeutrophilsAllylbenzene DerivativesanetholeAnisolesAnti-Bacterial Agents

Identifiers

PMID37027379
PMCPMC10081771
OpenAlexW4362692797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.